- CAS (CSE1L) signaling pathway in tumor progression and its potential as a biomarker and target for targeted therapy
Ming-Chung Jiang, 2016, Tumor Biology CrossRef - Identification of new therapeutic targets of bone cancers by proteomic strategies
Steven L. Wood et al, 2022, Bone Cancer CrossRef - CSE1L participates in regulating cell mitosis in human seminoma
Chunyan Liu et al, 2019, Cell Proliferation CrossRef - Roles of the CSE1L-mediated nuclear import pathway in epigenetic silencing
Qiang Dong et al, 2018, Proceedings of the National Academy of Sciences CrossRef - Proteomic Analysis Reveals GMP Synthetase as p53 Repression Target in Liver Cancer
Kerstin Holzer et al, 2017, The American Journal of Pathology CrossRef - Therapeutic Targeting of Nuclear Export Inhibition in Lung Cancer
Arjun Gupta et al, 2017, Journal of Thoracic Oncology CrossRef - RNA sequencing identified novel target genes forAdansonia digitatain breast and colon cancer cells
Omar S. El-Masry et al, 2021, Science Progress CrossRef - New Insights on Sperm Function in Male Infertility of Unknown Origin: A Multimodal Approach
Rita I. Pacheco et al, 2023, Biomolecules CrossRef - Expression of cellular apoptosis susceptibility (CAS) in the human testis and testicular germ cell tumors
Jianni Liu et al, 2019, Medical Oncology CrossRef - PHY34 inhibits autophagy through V-ATPase V0A2 subunit inhibition and CAS/CSE1L nuclear cargo trafficking in high grade serous ovarian cancer
Amrita Salvi et al, 2022, Cell Death & Disease CrossRef